Abbott Laboratories
DE ˙ XTRA ˙ US0028241000
75,22 € ↑1,20 (1,62%)
2026-06-03
AKTIENPREIS
SecurityDE:ABL / Abbott Laboratories
InstitutionClose Asset Management Ltd
Latest Disclosed Ownership6,535 shares
Latest Disclosed Value $ 670
Close Asset Management Ltd reports 0.83% decrease in ownership of ABL / Abbott Laboratories

On May 12, 2026 - Close Asset Management Ltd filed a 13F-HR form disclosing ownership of 6,535 shares of Abbott Laboratories (DE:ABL) valued at $580,439 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 10, 2026 disclosing 6,590 shares of Abbott Laboratories. The current value of the position is $491,563 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-12 2026-03-31 13F ABBOTT LABORATORIES COM NPV COM 002824100 6,535 -55 -0.83 1 0.0182
2026-02-10 2025-12-31 13F ABBOTT LABORATORIES COM NPV COM 002824100 6,590 0 0.00 1 0.0183
2025-11-12 2025-09-30 13F ABBOTT LABORATORIES COM NPV COM 002824100 6,590 -106 -1.58 1 0.0196
2025-08-12 2025-06-30 13F ABBOTT LABORATORIES COM NPV COM 002824100 6,696 -3,117 -31.76 1 -100.00 0.0266
2025-05-06 2025-03-31 13F ABBOTT LABORATORIES COM NPV COM 002824100 9,813 -190 -1.90 1 0.00 0.0374
2025-01-28 2024-12-31 13F ABBOTT LABORATORIES COM NPV COM 002824100 10,003 10,003 1 0.0319
2024-11-12 2024-09-30 13F ABBOTT LABORATORIES COM NPV COM 002824100 0 -11,853 -100.00 0 -100.00
2024-08-07 2024-06-30 13F ABBOTT LABORATORIES COM NPV COM 002824100 11,853 -260 -2.15 1 0.00 0.0419
2024-05-14 2024-03-31 13F ABBOTT LABORATORIES COM NPV COM 002824100 12,113 -739,414 -98.39 1 -98.78 0.0503
2024-02-08 2023-12-31 13F ABBOTT LABORATORIES COM NPV COM 002824100 751,527 741,285 7,237.70 83 3.4628
2023-10-11 2023-09-30 13F ABBOTT LABORATORIES COM NPV COM 002824100 10,242 147 1.46 1 -100.00 0.0512
2023-07-26 2023-06-30 13F ABBOTT LABORATORIES COM NPV COM 002824100 10,095 350 3.59 1 0.0516
2023-04-19 2023-03-31 13F ABBOTT LABORATORIES COM NPV COM 002824100 9,745 1,238 14.55 1 0.0489
2023-01-27 2022-12-31 13F ABBOTT LABORATORIES COM NPV COM 002824100 8,507 99 1.18 1 -100.00 0.0496
2022-10-26 2022-09-30 13F ABBOTT LABORATORIES COM NPV COM 002824100 8,408 0 0.00 814 -11.04 0.0461
2022-07-29 2022-06-30 13F ABBOTT LABORATORIES COM NPV COM 002824100 8,408 527 6.69 915 -17.49 0.0433
2022-04-27 2022-03-31 13F ABBOTT LABORATORIES COM NPV COM 002824100 7,881 0 0.00 1,109 0.00 0.0396
2022-01-27 2021-12-31 13F ABBOTT LABORATORIES COM NPV COM 002824100 7,881 -15 -0.19 1,109 18.86 0.0396
2021-11-04 2021-09-30 13F ABBOTT LABORATORIES COM NPV COM 002824100 7,896 -840 -9.62 933 -7.90 0.0455
2021-07-27 2021-06-30 13F ABBOTT LABORATORIES COM NPV COM 002824100 8,736 285 3.37 1,013 0.00 0.0484
2021-05-07 2021-03-31 13F ABBOTT LABORATORIES COM NPV COM 002824100 8,451 1,110 15.12 1,013 26.00 0.0539
2021-01-22 2020-12-31 13F ABBOTT LABORATORIES COM NPV COM 002824100 7,341 601 8.92 804 9.69 0.0603
2020-10-30 2020-09-30 13F ABBOTT LABORATORIES COM NPV COM 002824100 6,740 -415 -5.80 733 12.08 0.0498
2020-07-28 2020-06-30 13F ABBOTT LABORATORIES COM NPV COM 002824100 7,155 150 2.14 654 18.26 0.0486
2020-05-05 2020-03-31 13F ABBOTT LABORATORIES COM NPV COM 002824100 7,005 1,585 29.24 553 17.41 0.0492
2020-01-22 2019-12-31 13F ABBOTT LABORATORIES COM NPV COM 002824100 5,420 650 13.63 471 18.05 0.0368
2019-11-06 2019-09-30 13F ABBOTT LABORATORIES COM NPV COM 002824100 4,770 -920 -16.17 399 -16.35 0.0352
2019-08-01 2019-06-30 13F ABBOTT LABORATORIES COM NPV COM 002824100 5,690 1,290 29.32 477 35.51 0.0371
2019-05-10 2019-03-31 13F ABBOTT LABORATORIES COM NPV COM 002824100 4,400 3,786 616.61 352 576.92 0.0300
2019-01-28 2018-12-31 13F XILINX INCORPORATED COM US$0.01 COM 002824100 614 -3,786 -86.05 52 -83.90 0.0058
2018-11-09 2018-09-30 13F/A-2 ABBOTT LABORATORIES COM NPV COM 002824100 4,400 4,400 323 0.0261
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.